基于瑞典国家白内障登记数据的囊膜并发症复合风险评分:与手术量的关系
本研究基于瑞典国家白内障登记数据(2007-2016年),分析白内障手术病例组合与囊膜并发症的关系,并构建复合风险评分。结果显示,高手术量术者(年≥500例)的复合风险评分显著低于低、中手术量术者,且2007-2016年间高危患者比例下降,可能有助于解释囊膜并发症减少及高手术量术者并发症率较低的现象。
要点
- 复合风险评分基于术前和术中参数,与囊膜并发症风险相关。
- 高手术量术者(年≥500例)的复合风险评分显著低于低、中手术量术者。
- 2007-2016年间,高龄、低视力及术中困难患者比例下降。
核心结论
- 基于国家白内障登记术前和术中参数计算的病例组合可能有助于解释2007-2016年囊膜并发症的减少以及高手术量术者中观察到的较低并发症率。
研究设计与样本
- 基于登记的研究,纳入2007年至2016年间接受白内障手术的瑞典患者。
- 回顾性分析人口学、眼合并症、术中困难及囊膜并发症数据,并与术者手术量编码数据关联。
- 采用单因素分析和逻辑回归,并构建复合风险评分。
主要发现
- 与囊膜并发症显著相关的术前和术中变量包括:最佳矫正视力(BCVA)≤0.1(aOR 1.82,P<0.001)、假性剥脱(PEX)(aOR 1.53,P<0.001)、除年龄相关性黄斑变性(AMD)、糖尿病视网膜病变、青光眼或角膜滴状变性以外的威胁视力眼合并症(aOR 1.35,P=0.006)、使用台盼蓝(aOR 1.76,P<0.001)、机械性瞳孔扩张(aOR 1.36,P=0.024)以及虹膜钩用于撕囊缘(aOR 6.99,P<0.001)。
- 发生囊膜并发症患者的复合风险评分为3.09±6.40(均值±标准差),无并发症手术为1.28±1.66(P<0.001)。
- 高手术量白内障术者(年≥500例)的复合风险评分(均值风险评分≤1.28;范围1.01-2.02)显著低于低手术量术者(1.34±0.56;范围1.00-4.55)和中手术量术者(1.49±0.58;范围1.01-5.19)。
- 2007-2016年间,年龄>88岁、BCVA≤0.1及术中困难的患者比例下降。
关键数值与推荐
- 复合风险评分在囊膜并发症患者中为3.09±6.40,无并发症手术为1.28±1.66(P<0.001)。
- 高手术量术者(年≥500例)复合风险评分均值≤1.28(范围1.01-2.02),低手术量术者为1.34±0.56(范围1.00-4.55),中手术量术者为1.49±0.58(范围1.01-5.19)。
临床怎么用
- 复合风险评分可用于评估白内障手术患者的囊膜并发症风险,辅助病例组合调整和术者手术量规划。
- 高手术量术者可能处理较低风险病例组合,解释其较低并发症率时需考虑病例组合差异。
局限性
- 本研究为基于登记数据的回顾性研究,可能存在未测量的混杂因素。
- 复合风险评分基于特定登记人群,外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate case mix in relation to capsule complication, possible associations between case mix and operation volume, and change in case mix over time. DESIGN: Register-based study. PARTICIPANTS: Swedish patients who underwent cataract surgery between 2007 and 2016. METHODS: Demographics and data on ocular comorbidity, intraoperative difficulties, and capsule complications were registered from 2007 to 2016 and analyzed retrospectively in relation to coded data on individual surgeons' operation volume. Single factor analysis and logistic regression were performed, and a composite risk score was created. MAIN OUTCOME MEASURES: Risk of capsule complication, given as adjusted and composite odds ratio in relation to cataract surgery volume. RESULTS: Preoperative and intraoperative variables significantly associated with capsule complications were best-corrected visual acuity (BCVA) ≤0.1 (decimal, adjusted odds ratio [aOR], 1.82; P < 0.001); pseudoexfoliation (PEX) (aOR, 1.53; P < 0.001); sight-threatening ocular comorbidity other than age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, or cornea guttata (aOR, 1.35; P = 0.006); use of Trypan blue (aOR, 1.76; P < 0.001); mechanical pupil dilation (aOR, 1.36; P = 0.024); and iris hooks at the rhexis margin (aOR, 6.99; P < 0.001). The composite risk score was 3.09 ± 6.40 (mean ± standard deviation) for patients with capsule complication and 1.28 ± 1.66 for uncomplicated procedures (P < 0.001). High-volume cataract surgeons (≥500 procedures yearly) had a significantly lower composite risk score (mean risk score ≤1.28; range, 1.01-2.02) compared with low- and medium-volume cataract surgeons (1.34 ± 0.56; range, 1.00-4.55 and 1.49 ± 0.58; range, 1.01-5.19), respectively. During the period 2007-2016, the proportion of patients aged >88 years, patients with BCVA ≤0.1, and patients with intraoperative difficulties decreased. CONCLUSIONS: Case mix, as calculated from a composite risk score based on preoperative and intraoperative parameters registered in the National Cataract Register (NCR), may contribute to the decrease in capsule complications from 2007 to 2016 and the lower complication rate observed in cases managed by high-volume cataract surgeons.
引用
- Zetterberg M, Kugelberg M, Nilsson I, et al. A Composite Risk Score for Capsule Complications Based on Data from the Swedish National Cataract Register: Relation to Surgery Volumes. Ophthalmology. 2020. PMID: 32710994. doi:10.1016/j.ophtha.2020.07.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。